SavedAdd your journal

Journals / European Archives of Medical Research / 2020 / Cilt: 36 - Sayı: 3

Added Value of SPECT/CT to Whole Body Scan Test Planar Imaging in Patients with Thyroid Cancer After Radioiodine 131 Therapy

Filiz ÖZÜLKER
Mehmet Tarık TATOĞLU
Tamer ÖZÜLKER
Halim ÖZÇEVİK
Tülay KAÇAR GÜVELİ
Mehmet MÜLAZIMOĞLU
Pages
183–191
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Difference between the number of detected lesions was found to be a statistically significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this retrospective study was to determine added value of single photon emission computed tomography (SPECT)/computed tomography (CT) imaging to whole body scan (WBS) planar imaging in patients with thyroid cancer after radioiodine 131 ablation therapy.Methods: Indications for treatment of radioactive ablation therapy were postsurgical ablation, recurrent or metastatic disease with high thyroglobulin level of 50 patients with thyroid cancer were evaluated.
📊
Key Findings & Data:Following 6 or 7 days after the between 50 and 300 mCi of radioiodine 131 administered orally in patients examined with WBS planar imaging, suspicion of metastasis evaluated with SPECT/CT imaging method.
💡
Conclusion & Impact:Difference between the number of detected lesions was found to be a statistically significant (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this retrospective study was to determine added value of single photon emission computed tomography (SPECT)/computed tomography (CT) imaging to whole body scan (WBS) planar imaging in patients with thyroid cancer after radioiodine 131 ablation therapy.Methods: Indications for treatment of radioactive ablation therapy were postsurgical ablation, recurrent or metastatic disease with high thyroglobulin level of 50 patients with thyroid cancer were evaluated. Following 6 or 7 days after the between 50 and 300 mCi of radioiodine 131 administered orally in patients examined with WBS planar imaging, suspicion of metastasis evaluated with SPECT/CT imaging method. Imaging techniques were evaluated by nuclear medicine specialist with over 10 years experience in thyroid cancer management. The number of lesions assessed with planar images and the number of lesions assessed with SPECT/CT were recorded. The difference between the level of significance was tested using Wilcoxon Signed Rank test, SPSS 12 software package. Special cases with lesion based analysis was performed by examining the reviews.Results: On planar images 188 foci were detected, on SPECT/CT images 196 foci were detected. Difference between the number of detected lesions was found to be a statistically significant (p

🔖

Cite This Article

ÖZÜLKER, F., TATOĞLU, M. T., ÖZÜLKER, T., ÖZÇEVİK, H., GÜVELİ, T. K., MÜLAZIMOĞLU, M. (2022). Added Value of SPECT/CT to Whole Body Scan Test Planar Imaging in Patients with Thyroid Cancer After Radioiodine 131 Therapy. European Archives of Medical Research, Cilt: 36 - Sayı: 3, 183–191. https://ajindex.com/articles/650408

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Chen AY, Jemal A, Ward EM. Increasing incidence of differantiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115:3801-7.
  2. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-41.
  3. Davies L, Ouellette M, Hunter M, Welch HG. The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope 2010;120:2446-51.
  4. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295:2164-7.
  5. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer Statistics, 2012. CA Cancer J Clin 2012;62:220-41. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
  6. Patton JA, Turkington TG. SPECT/CT physical principles and attenuation correction. J Nucl Med Technol 2008;36:1-10.
  7. Roarke MC, Nguyen BD, Pockaj BA. Applications of SPECT/CT in nuclear radiology. AJR Am J Roentgenol 2008;191:135-50.
  8. Delbeke D, Schöder H, Martin WH, Wahl RL. Hybrid imaging (SPECT/ CT and PET/CT): improving therapeutic decisions. Semin Nucl Med 2009;39:308-40.
  9. Seo Y, Mari C, Hasegawa BH. Technological Development and Advances in SPECT/CT. Semin Nucl Med 2008;38:177-98. Pérault C, Schvartz C, Wampach H, Liehn JC, Delisle MJ. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. J Nucl Med 1997;38:1234-42.
  10. Yamamoto Y, Nishiyama Y, Monden T, Matsumura Y, Satoh K, Ohkawa M. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med 2003;44:1905-10.
  11. Ruf J, Lehmkuhl L, Bertram H, Sandrock D, Amthauer H, Humplik B, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 2004;25:1177-82.
  12. Schmidt D, Szikszai A, Linke R, Bautz W, Kuwert T. Impact of 131I SPECT/ spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med 2009;50:18-23.
  13. Aide N, Heutte N, Rame JP, Rousseau E, Loiseau C, Amar MH, et al. Clinical relevance of single-photon emission computed tomography/compu